Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of β1-integrin by IPEC-J2 cells

Applied and Environmental Microbiology

Volumn 76, Issue 13, 2010, Pages 4461-4468

  Liu, Bianfang ^a   Yin, Xianhua ^b,d   Feng, Yanni ^a   Chambers, James R ^b   Guo, Aiguang ^a   Gong, Joshua ^b   Zhu, Jing ^c   Gyles, Carlton L ^d  

^a NORTHWEST A F UNIVERSITY   (China)

^b GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ADHERENCE; CELL LINES; COMPLEMENTATION; DELETION MUTANTS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HUMAN COLON; INTEGRINS; INTESTINAL EPITHELIAL CELLS; LARYNGEAL CARCINOMAS; MUTANT STRAIN; NEGATIVE MUTANTS; NUCLEOLIN; REVERSE TRANSCRIPTASES; SYNTHASES; WILD TYPES;

BACTERIOLOGY; CELL CULTURE; ESCHERICHIA COLI; RESTORATION;

CELLS;

BETA1 INTEGRIN; GALACTOSYLTRANSFERASE; NUCLEOLIN; PHOSPHOPROTEIN; RNA BINDING PROTEIN; UDP GALACTOSE LACTOSYLCERAMIDE ALPHA 1 4 GALACTOSYLTRANSFERASE; UDP-GALACTOSE-LACTOSYLCERAMIDE ALPHA 1-4-GALACTOSYLTRANSFERASE; VEROTOXIN 2;

COLIFORM BACTERIUM; CYTOLOGY; ENZYME ACTIVITY; LIPID; PROTEIN; TOXIN;

ANIMAL; ARTICLE; BACTERIUM ADHERENCE; CELL LINE; COLON; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; ESCHERICHIA COLI O157; HUMAN; JEJUNUM; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SWINE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD29; BACTERIAL ADHESION; CELL LINE; CELL LINE, TUMOR; COLON; EPITHELIAL CELLS; ESCHERICHIA COLI O157; GALACTOSYLTRANSFERASES; HUMANS; JEJUNUM; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; SHIGA TOXIN 2; SWINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ESCHERICHIA COLI O157:H-; SUS;

EID: 77954249989     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00182-10     Document Type: Article

References (30)

1. Best, A., R. M. La Ragione, W. A. Cooley, C. D. O'Connor, P. Velge, and M. J. Woodward. 2003. Interaction with avian cells and colonisation of specific pathogen free chicks by Shiga-toxin negative Escherichia coli O157:H7 (NCTC 12900). Vet. Microbiol. 93:207-222.
2. Cornick, N. A., A. F. Helgerson, and V. Sharma. 2007. Shiga toxin and Shiga toxin-encoding phage do not facilitate Escherichia coli O157:H7 colonization in sheep. Appl. Environ. Microbiol. 73:344-346.
3. Elliott, S. J., S. W. Hutcheson, M. S. Dubois, J. L. Mellies, L. A. Wainwright, M. Batchelor, G. Frankel, S. Knutton, and J. B. Kaper. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol. Microbiol. 33:1176-1189.
4. Frankel, G., O. Lider, R. Hershkoviz, A. P. Mould, S. G. Kachalsky, D. C. Candy, L. Cahalon, M. J. Humphries, and G. Dougan. 1996. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to betal integrins. J. Biol. Chem. 271:20359-20364.
5. Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mbl. Microbiol. 30:911-921.
6. Frankel, G., A. D. Phillips, L. R. Trabulsi, S. Knutton, G. Dougan, and S. Matthews. 2001. Intimin and the host cell-is it bound to end in Tir(s)? Trends Microbiol. 9:214-218.
7. Hoffman, M. A., C. Menge, T. A. Casey, W. Laegreid, B. T. Bosworth, and E. A. Dean-Nystrom. 2006. Bovine immune response to Shiga-toxigenic Escherichia coli O157:H7. Clin. Vaccine Immunol. 13:1322-1327.
8. Hughes, A. K., Z. Ergonul, P. K. Stricklett, and D. E. Kohan. 2002. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. J. Am. Soc. Nephrol. 13: 2239-2245.
9. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
10. Johannes, L., and W. Romer. 2009. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8:105-116.
11. Kaper, J. B., and M. A. Karmali. 2008. The continuing evolution of a bacterial pathogen. Proc. Natl. Acad. Sci. U. S. A. 105:4535-4536.
12. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
13. Kojima, Y., S. Fukumoto, K. Furukawa, T. Okajima, J. Wiels, K. Yokoyama, Y. Suzuki, T. Urano, and M. Ohta. 2000. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids. J. Biol. Chem. 275:15152-15156.
14. LeBlanc, J. J. 2003. Implication of virulence factors in Escherichia coli O157:H7 pathogenesis. Crit. Rev. Microbiol. 29:277-296.
15. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
16. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolyticuremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
17. Meyers, K. E., and B. S. Kaplan. 2000. Many cell types are Shiga toxin targets. Kidney Int. 57:2650-2651.
18. Murphy, K. C., and K. G. Campellone. 2003. Lambda red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4:11.
19. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichis coli O157:H7. Nature 409:529-533.
20. Poirier, K., S. P. Faucher, M. Beland, R. Brousseau, V. Gannon, C. Martin, J. Harel, and F. Daigle. 2008. Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect. Immun. 76:4814-4822.
21. Ritchie, J. M., C. M. Thorpe, A. B. Rogers, and M. K. Waldor. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71: 7129-7139.
22. Robinson, C. M., J. F. Sinclair, M. J. Smith, and A. D. O'Brien. 2006. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc. Natl. Acad. Sci. U. S. A. 103:9667-9672.
23. Schuller, S., R. Heuschkel, F. Torrente, J. B. Kaper, and A. D. Phillips. 2007. Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect. 9:35-39.
24. Schweizer, H. D. 1993. Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15:831-834.
25. Sheng, H., J. Y. Lim, H. J. Knecht, J. Li, and C. J. Hovde. 2006. Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect. Immun. 74:4685-4693.
26. Sinclair, J. F., E. A. Dean-Nystrom, and A. D. O'Brien. 2006. The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and betal integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo. Infect. Immun. 74: 1255-1265.
27. Sinclair, J. F., and A. D. O'Brien. 2004. Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor. J. Biol. Chem. 279:33751-33758.
28. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin- producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
29. Tarr, P. I., M. A. Neill, C. R. Clausen, J. W. Newland, R. J. Neill, and S. L. Moseley. 1989. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J. Infect. Dis. 159:344-347.
30. Yin, X., J. R. Chambers, R. Wheatcroft, R. P. Johnson, J. Zhu, B. Liu, and C. L. Gyles. 2009. Adherence of Escherichia coli O157:H7 mutants in vitro and in ligated pig intestines. Appl. Environ. Microbiol. 75:4975-4983.